Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Patients diagnosed as hypertensive
Untreated confirmed hypertensive patients (consistent SBP \>140 mm Hg or DBP \>90 mm Hg)
Uncontrolled hypertensive patients (Consistent SBP \>140 mm Hg or DBP \>90 mm Hg) on one drug therapy.
Uncontrolled hypertensive patients (Consistent SBP \>140 mm Hg or DBP \>90 mm Hg) on two drug therapy.
You may not be if
Inability to switch from all prior antihypertensive medications safely as required by the protocol.
Need for drugs other than study drugs at the time of baseline.
Patients with SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg at screening.
Patients on four or more antihypertensive drugs at screening.
Pregnant or nursing (lactating) women.
Patients with diabetes mellitus
Patients with heart diseases and any other disease
Clareo Health | Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
